• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.

作者信息

Roy B, Chou M C, Field J B

出版信息

J Clin Endocrinol Metab. 1980 Mar;50(3):475-9. doi: 10.1210/jcem-50-3-475.

DOI:10.1210/jcem-50-3-475
PMID:6987253
Abstract

The time course of action of regular and NPH insulins injected sc was studied in 15 insulin-treated diabetics over a 24-h period during which they received a constant infusion of glucose. The blood glucose began to decline in 1.2 +/- 0.1 h (range, 0.5--2) and reached its nadir in 5.7 +/- 0.3 h (range, 4--8) after the sc injection of regular insulin. The peak effect of regular insulin usually persisted for several hours, and the total duration of action was 16.2 +/- 1.1 h (range, 9--24). Both the time of peak effect and the total duration of action were considerably prolonged compared to data provided in standard textbooks. Free insulin increased to a peak in 2.7 +/- 0.3 h (range, 1--4) after regular insulin injection and then returned to baseline by 8.8 +/- 0.96 h. Subcutaneous injection of NPH insulin decreased the blood glucose by 2.4 +/- 0.5 h (range, 1--7), with a maximal effect at 11.0 +/- 1.4 h (range, 5--19). The total duration of effect on blood glucose was 25.1 +/- 0.7 h (range, 20--29). These values are similar to those in standard textbooks. Although the total insulin levels increased after the injection of NPH insulin, there was very little if any elevation in free insulin. Recognition of the prolonged effect of regular insulin is important in establishing an insulin treatment regime for diabetic patients.

摘要

相似文献

1
Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.
J Clin Endocrinol Metab. 1980 Mar;50(3):475-9. doi: 10.1210/jcem-50-3-475.
2
Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.常规胰岛素在糖尿病患者中的长效作用:与循环胰岛素抗体无关。
J Clin Endocrinol Metab. 1986 Apr;62(4):621-7. doi: 10.1210/jcem-62-4-621.
3
[Clinical use of NPH insulin (author's transl)].中效胰岛素的临床应用(作者译)
Dtsch Med Wochenschr. 1976 Jun 4;101(23):886-9. doi: 10.1055/s-0028-1104135.
4
Human (recombinant DNA) and porcine NPH insulins are unequally effective in diabetic patients. A comparative study using continuous blood glucose monitoring.人(重组DNA)胰岛素和猪NPH胰岛素对糖尿病患者的疗效不同。一项使用连续血糖监测的对比研究。
Acta Diabetol Lat. 1984 Jul-Sep;21(3):211-7. doi: 10.1007/BF02642894.
5
Absorption kinetics of regular and isophane (NPH) insulin in the normal dog.普通犬体内正规胰岛素和低精蛋白锌胰岛素(NPH)的吸收动力学
Domest Anim Endocrinol. 1987 Jan;4(1):43-50. doi: 10.1016/0739-7240(87)90037-3.
6
[Action profile of a semisynthetic human isophane zinc insulin compared with customary isophane insulin].[一种半合成人低精蛋白锌胰岛素与常规低精蛋白胰岛素相比的作用情况]
Diabete Metab. 1992 Nov-Dec;18(6):445-50.
7
The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique.I型糖尿病患者皮下注射常规胰岛素的药代动力学:采用葡萄糖钳夹技术进行评估。
J Clin Endocrinol Metab. 1986 Sep;63(3):689-94. doi: 10.1210/jcem-63-3-689.
8
Intermediate-acting insulin preparations: NPH and lente.中效胰岛素制剂:NPH和lente。
Diabetes Care. 1980 Sep-Oct;3(5):623-6. doi: 10.2337/diacare.3.5.623.
9
Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.2型糖尿病患者睡前注射甘精胰岛素或中性鱼精蛋白锌胰岛素后的夜间葡萄糖代谢情况。
J Clin Endocrinol Metab. 2008 Oct;93(10):3839-46. doi: 10.1210/jc.2007-2871. Epub 2008 Jul 8.
10
Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin.危重症患者接受持续肠内营养和静脉普通胰岛素时,使用中效胰岛素过渡治疗。
JPEN J Parenter Enteral Nutr. 2013 Jul;37(4):506-16. doi: 10.1177/0148607112458526. Epub 2012 Aug 22.

引用本文的文献

1
National athletic trainers' association position statement: management of the athlete with type 1 diabetes mellitus.美国国家运动训练师协会立场声明:1型糖尿病运动员的管理
J Athl Train. 2007 Oct-Dec;42(4):536-45.
2
Absorption of isophane (NPH) insulin and its clinical implications.低精蛋白锌胰岛素(NPH胰岛素)的吸收及其临床意义。
Br Med J (Clin Res Ed). 1982 Jul 17;285(6336):159-62. doi: 10.1136/bmj.285.6336.159.
3
Recent developments in the management of diabetes mellitus.糖尿病管理的最新进展
Indian J Pediatr. 1982 Jul-Aug;49(399):589-604. doi: 10.1007/BF02834568.
4
The new insulins. Their characteristics and clinical indications.新型胰岛素。其特点及临床适应证。
Drugs. 1982 Nov;24(5):401-13. doi: 10.2165/00003495-198224050-00003.
5
Smoking and insulin absorption.吸烟与胰岛素吸收
Br Med J (Clin Res Ed). 1984 Oct 20;289(6451):1077. doi: 10.1136/bmj.289.6451.1077-b.